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ABSTRACT 
 
To date no problem-free method exists for the immobilisation of free-ranging walruses 
(Odobenus rosmarus). In the period 1989-2001, 69 immobilisations with etorphine HCl were 
performed by remote darting of 41 individual free-ranging adult Atlantic walruses (O. r. 
rosmarus), with body masses 633 - 1883 kg, as a prerequisite for the attachment of radio 
tracking and dive recording instruments, and for studies of metabolism. Ten individuals were 
immobilised several times. We present data on these 69 immobilisations and evaluate the 
method. Full immobilisation was achieved in 58 cases (84 %). The animals were 
insufficiently restrained in 6 cases (9 %) and 5 animals died (7 %) following the 
immobilisation. The animals were fully immobilised and approachable after 5 min (n = 38, 
range = 1.9 - 12.4 min, SD = 2.2) with a dose of etorphine of 6.1 μg/kg (range 2.4 - 12.6 μg 
/kg, SD = 2.4). Induction time was negatively correlated with the dosage of etorphine. 
Etorphine-induced apnoea lasted 13.7 min (n = 36, range 17.0 - 26.7 min, SD = 5.1) and was 
reversed by multiple doses of the antagonist diprenorphine HCl. The first dose of antagonist 
of 12.2 mg (n = 39, range 6.0 - 21.0 mg, SD = 3.5) was administered 8.4 min (n = 38, 
range 4.7 - 18.0 min, SD = 2.8) after injection of the agonist. The total dose of diprenorphine 
per animal ranged between 7.7 and 41.7 μg/kg (n = 31, mean = 17.2 μg/kg, SD = 7.5). For 
some animals blood pH values were measured following the apnoea and reached low levels 
(min pH 6.8). For animals that were immobilised several times there were no indications of 
changed sensitivity to etorphine as reflected in unchanged induction times. Mortalities could 
neither be related to the doses of agonist and antagonist, nor to the times of administration of 
the drugs. From this (n = 69) and other (n = 103) studies involving etorphine immobilisation 
of walruses (both Atlantic and Pacific) the overall success rate is 83 % (8 % casualty rate). 
We conclude that the combination etorphine-diprenorphine is suitable for both single and 
multiple immobilisations of walruses provided that (a) a casualty rate of 7-8% is acceptable 
(b) the antagonist diprenorphine is administered fast and well into a tissue with good blood 
irrigation, and (c) the animal is promptly intubated endotracheally to facilitate the restoration 
of breathing after drug-induced apnoea. 
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INTRODUCTION 
 
Chemical immobilisation is typically necessary in studies of pinnipeds that 
require contact with the animals for the attachment of instruments or 
physiology experiments. This is the case when working in the field with large 
and potentially dangerous species like walrus (Odobenus rosmarus). Captive 
and free-ranging Atlantic (O. r. rosmarus) and Pacific (O. r. divergens) 
walruses have been occasionally immobilised for surgery or for research 
purposes using a number of different protocols and drugs in the quest of a 
reliable method that is safe to the animals and the researchers. A series of 
anaesthetic agonist agents have been employed, alone or in combinations, for 
surgery of captive walrus. These include, for example, ketamine (Hagenbeck 
et al. 1975), or meperidine sulfate and thiamylal (Cornell and Antrim 1987). 
On free-ranging walruses, several drugs, alone or in combinations, have been 
employed: phencyclidine and acepromazine (DeMaster et al. 1981), 
tiletamine and zolazepam (Griffiths et al. 1993, Hills 1992, Stirling and Sjare 
1988), medetomidine and ketamine (Lydersen et al. 1992), etorphine (Born 
and Knutsen 1992a, Griffiths et al. 1993, Hills 1992), carfentanil (Hills 1992, 
Lanthier et al. 1999, see Table 1). However, the descriptions of the effects 
and the response of the animals to the different drugs are fragmentary, and 
more important, none has proven optimal for this species. 
 
Remote, intramuscular administration of immobilising agents (by dart or 
extension syringe) is preferred when working with large or dangerous species 
in the wild (Lynch et al. 1999). Only the potent synthetic opioids carfentanil 
and etorphine simultaneously satisfy the requirements of a minimum injection 
volume, rapid induction, and the existence of an antagonist drug to control 
the reversal of the effects of the agonist drug. The use of carfentanil alone and 
antagonised with naltrexone has been described for only four Pacific walruses 
(Hills 1992) and for six Atlantic walruses (Lanthier et al. 1999). The paucity 
of data for carfentanil does not allow a thorough evaluation of this 
immobilising agent, while the relatively more extensive use of etorphine (172 
immobilisations) provides a good basis for an evaluation. 
 
Etorphine antagonized with diprenorphine was first used in 1988 for 
immobilisation of Pacific walrus in Alaska (Hills 1992), and in 1989 for 
Atlantic walrus in Greenland (Born and Knutsen 1990, Knutsen and Born 
1994). In these and subsequent field studies of walrus (e.g. Griffiths et al. 
1993) the number of animals treated per season has been relatively low. 
Therefore the accumulation of data for evaluation of the feasibility of using a 
particular drug for immobilisation of walrus has been a slow process. More 
recently walruses have been immobilised with etorphine in the
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Table 1. Summary of the immobilisations of walruses reported in the 
literature and in the present study. The drug employed and the number of 
attempts, partial immobilisations and casualties are reported with an 
indication of the geographical area and the references for each group. 
 
Drug 
Immobili
-sation 
Attempts 
Partial 
Immobili-
sations 
Casualties Location 
Ketamine 1   
Captivity 
(Hagenbeck et al. 
1975) 
Ketamine 1 1  
Alaska (DeMaster 
et al. 1981) 
Phencyclidine 1 1  
Alaska (DeMaster 
et al. 1981) 
Phencyclidine 
and 
Acepromazine 
7 2 2 
Alaska (DeMaster 
et al. 1981) 
Meperedine 
Sulfate and 
Thiamidal 
1   
Captivity (Cornell 
and Antrim 1987) 
Tiletamine and 
Zolazepam 
10 3 1 
Canada (Stirling 
and Sjare 1988) 
7 1 3 
Alaska  (Hills 
1992) 
3  1 
Svalbard 
(Griffiths et al. 
1993) 
Medetomidine 
and Ketamine 
1   
Svalbard 
(Lydersen et al. 
1992) 
Carfentanil 
4   
Alaska (Hills 
1992) 
6   
Canada (Lanthier 
et al. 1999) 
Etorphine 
59 8 5 
Alaska (Hills 
1992) 
38 2 1 
Svalbard 
(Griffiths et al. 
1993) 
6  2 
Svalbard 
(Griffiths 
unpublished) 
69 6 5 This study 
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Norwegian Arctic but unfortunately no data on these procedures is available. 
Preliminary data from some of the early work have been partially presented 
in technical reports (Born and Knutsen 1990, Born and Knutsen 1992a, Born 
and Wiig 1995, Knutsen 1993), which are difficult to obtain. In this paper we 
report on more recent immobilizations in Greenland and Franz Josef Land 
and use them and previous studies to summarise and evaluate the experience 
acquired to date in the use of etorphine for the immobilisation of free-ranging 
Atlantic walruses. 
 
MATERIALS AND METHODS 
 
During the open water season in June-August 1989-92, August 1994, and 
July-August 1999-2001 a total of 69 immobilisation attempts were performed 
using etorphine on 41 individual adult Atlantic walruses (37 males, 4 
females). The animals were darted at different locations in Greenland (Kane 
Basin in NW Greenland, Young Sound and Dove Bay in NE Greenland) and 
Franz-Josef Land (Apolonov, Kuhn, Hayes and Hooker Island) both on land 
and on ice floes. Ten out of the 37 males were treated repeatedly both within 
the same season and in different years (Table 2).  
 
 
Table 2. List of multiple immobilisations of the same individual 
walruses (ID) by etorphine/ diprenorphine in NE Greenland 
between 1989 and 2001. The figures represent the number of 
immobilisations of the same individual within the same summer 
season. 
 
ID 1989 1990 1999 2000 2001 
1989-3 2 1  1 2 
1989-4 1 1    
1999-1   1 1 1 
2000-1    4  
2000-2    3 3 
2000-3    2  
2000-4    3  
2000-6    3 2 
2000-8    2 3 
2001-9     2 
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Immobilisation protocol 
The effect of etorphine was reversed by the antagonist diprenorphine. The 
drug concentrations used for immobilisation at Franz Josef Land were 9.8 
mg/ml etorphine and 12 mg/ml diprenorphine (Cyprenorphine, C-Vet Ltd., 
Bury St. Edmunds, Suffolk, U.K.). In Greenland the concentrations used 
were: 4 mg/ml (EtorfinVet. Pharmacia, Denmark) and 9.8 mg/ml (either 
“M99” Vericore Ltd., Dundee, Scotland or Etorfin Vet., Pharmacia, 
Denmark) for etorphine and 6 mg/ml (Diprenorfin Vet., Pharmacia, 
Denmark) and 12 mg/ml (“M5050”, 12 mg/ml, Vericore Ltd., Dundee, 
Scotland) for diprenorphine respectively. As the actual weight of the animals 
was unknown, dosage was based on experience and only on adult walruses in 
good condition were immobilised.  
 
The animals did not receive any pre-anaesthetic medication. The drug was 
usually delivered after the animals had settled down on the terrestrial haulout 
and were resting. The etorphine was delivered in 3 ml plastic darts equipped 
with a 10 cm-long needle plain (Vario dart, Telinject USA, 9316 Soledad 
Canyon Rd., Saugas, California 91350, U.S.A.) which were shot using a 
11 mm-gauge CO2 powered darting gun (Daninject, Børkop, Denmark, and 
Telinject, Römerberg, Germany). Diprenorphine was administered by hand-
injection. Syringes with 2 mm-gauge and 8 or 10 cm-long, plain needles were 
used to secure the deposition of the antagonist in the muscle tissue under the 
thick skin and blubber layer. 
 
All time measures reported in this paper are relative to the time of injection 
of etorphine. Important events during the immobilisation were: 
 
a) Induction time: Time elapsed between impact of the dart (injection of 
the drug) and time of approach (i.e. the animal was unable to move 
and typically had stopped breathing 30-60 sec before approach)  
 
b) Apnoea: Time elapsed between cessation of breathing (estimated to 
30 sec before approach if not directly observed) and first, deep breath 
measured with a digital chronometer (Casio, Japan). 
 
The immobilisation protocol employed was initially developed in Greenland 
in 1989, adjusted in subsequent studies and was basically similar to the one 
described in Griffiths et al. (1993) and Lanthier et al. (1999). 
 
Most animals were immobilised during afternoons and evenings when 
walruses prefer to haul out (Born and Knutsen 1997). Furthermore, during the 
afternoons the herd of walruses was less tightly packed (Born and Knutsen 
1990). It then became easier to select a suitable animal for darting (i.e. ideally 
an animal with tusks that were large enough to carry instruments and that 
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presented calm behaviour), thus causing a minimum of disturbance to the 
other animals. When working in the pack ice it was preferred to select animals 
that appeared relaxed and were not associated with calves and other sub-
adults that, if frightened, might cause acute disturbance. Furthermore the floes 
used for hauling out had to be large enough for the handling of the drugged 
animal (floe size > 50 m2). The darts were shot from a distance of 15 - 40 m. 
The point of aim was chosen to ensure maximum penetration of the needle, 
based on experience and confirmed by visual inspection, and optimal drug 
delivery in the muscular tissue with minimal disturbance. We also attempted 
to hit a body location out of the animal’s field of sight because viewing the 
dart might have induced a reaction in the darted subject. Dart impact sites 
during immobilisation events were: in the upper dorsal region (19); the lower 
dorsal region (19); the flank (11); ventral region (4); a limb (1); not recorded 
(15). 
 
Etorphine can induce respiratory depression (Alford et al. 1974), and in 
walrus drug-induced apnoea is an unavoidable side-effect of the 
administration of etorphine (Griffiths et al. 1993). To minimize the duration 
of the apnoeic period and therefore the risk of death by suffocation, the 
antagonist diprenorphine was administered immediately after approach. The 
first dose of antagonist was either administered intramuscularly in the 
shoulder or lumbar region (n = 51), intravenously (n = 5) or in the highly 
vascularized tongue (n = 7) if muscle tonus in the jaw region did not prevent 
opening the mouth.  
 
In 2000 and 2001 the walruses were subjects of physiology studies that 
involved taking repeated blood samples for an extended period while the 
animals were on land. To extend the period when the animals were tractable 
after they had regained regular breathing, following the injection of 
diprenorphine, 6 of the 32 animals were given small amounts of 
medetomidine (“Domitor Forte”, 10 mg/ml, Orion Pharma, Turku, Finland; 
Griffiths et al. 2014). The medetomidine mean delivery time was 45 min from 
the etorphine injection (n = 6, range 30 – 78 min, SD = 15). Physiological and 
behavioural data for these animals are included in this analysis only up to the 
delivery of medetomidine. Data sampled after the administration of 
medetomidine were excluded from the analysis of the characteristics of the 
recovery from immobilisation by etorphine alone and are included in Griffiths 
et al. (2014). 
 
In 1999-2001 the animals were routinely intubated with an endotracheal tube 
(Cook Large Animal Veterinary Products, 38-mm internal diameter). The 
intubation, in each case, was first attempted blindly and if this proved 
unsuccessful, the tube was guided by the operator’s hand down the throat of 
the animal. In this case the operator’s fingers helped locate and open the 
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epiglottis, and facilitated the insertion of the tube into the trachea. Inflating 
the cuff was normally unnecessary as airtightness was ensured by the 
muscular compression of the tube. 
 
Animal monitoring during immobilisation and recovery 
In 23 cases breathing rate was recorded prior to immobilisation. Breathing 
rate was also routinely recorded during immobilisation. 
 
Heart rate of immobilised animals was monitored with an electronic pulse 
meter (Exersentry, Respironics Instruments, Inc., Monroeville, Pennsylvania 
15146, U.S.A.) equipped with four sensors connected to 6 cm long needles 
inserted, as far as possible from each other, through the skin.  
 
Body temperature was measured in two places with an electronic 
thermometer (DM852, Ellab, Copenhagen, Denmark): a blunt probe was 
inserted approximately 20 cm in the rectum and a needle probe was inserted 
in a hind limb 2 – 4 cm below the surface of the skin, the latter to monitor 
body surface temperature. The temperature values were not recorded 
systematically and were used only as a warning of overheating. 
 
In 1999-2001 a catheter (Becton-Dickinson Secalon-T, 2.0 mm * 160 mm, 
Medisinsk Utstyr AS, Oslo, Norway) was inserted into the epidural vertebral 
venous sinus (n = 43) which provided access for blood sampling and 
intravenous drug delivery. In five animals blood pH-values were measured in 
the field by use of i-Stat Portable Clinical Analyzer (i-STAT Corporation, 104 
Windsor Center Dr., East Windsor, NJ 08520, USA). 
 
Standard and zoological body length and axillary girth were measured in the 
field and were subsequently used to estimate total body mass (TBM) 
according to methods in Born et al. (2003). For three walruses which were 
immobilised on pack ice, TBM was estimated by comparing tusk dimensions 
with a TBM-at-age curve established from walruses sampled from the 
Greenlandic subsistence catch in north-western Greenland (Born unpublished 
data). In 8 cases estimates of TBM were not available. 
 
Statistical analysis 
Time and temperature data were log-transformed when necessary to obtain 
equality of variances and homoscedasticity assumed in parametric tests. The 
assumed significance level in all the tests was p = 0.05. 
 
The data were subsequently sorted into two groups: group A includes animals 
immobilised only once (31 individuals) and the first immobilisation for 
animals treated more than once (10 individuals) giving a total of 41 
immobilisations; and group B comprising only the animals that were 
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subjected to repeated immobilisations (10 individuals, 38 immobilisations 
including the first). 
 
Differences between males and females for dose of etorphine administered, 
induction time, duration of apnoea, antagonist injection time, antagonist first 
dose and time of first breath after induction were examined using a Mann-
Whitney U-test. In this and subsequent tests on group A data we excluded one 
animal which had an unusually long induction time. In this walrus the dart 
only penetrated 4 cm into the animal and presumably the agonist was injected 
into the blubber.  
 
On group A, linear regression analysis was employed to evaluate the effects 
of the dose of agonist on the induction time and the duration of apnoea and of 
the time between the administration of the agonist and the antagonist on the 
duration of apnoea. Due to missing data, the differences in pulse and body 
temperature between the apnoeic and post-apnoeic period were tested by use 
of unpaired t-tests. 
 
The cumulative effect of consecutive immobilisations of the same individual 
within the same season (group B) was investigated. The relative dose of 
etorphine on the log transformed induction time and log transformed apnoea 
duration was tested with and without the effect of the interaction between the 
two independent variables (i.e. relative dose of etorphine and time for 
etorphine administration and time from the previous immobilisation). 
Similarly, the cumulative effect of the time for diprenorphine administration 
was tested on the log transformed apnoea duration with and without the 
interaction between the two independent variables (i.e. time between 
etorphine and diprenorphine administration and time from the previous 
immobilisation). A spatial Gaussian correlation model for unequally spaced 
repeated measures including the random effect of the individual walrus 
(SAS PROC MIX procedure) was used (Littel et al. 1996) for this purpose. 
 
The circumstances of mortality events were investigated by bootstrapping 
100 times and tested against etorphine dosage, diprenorphine dosage and time 
of delivery with respect to etorphine administration. Chi-square tests were 
employed to test the effect of the researcher in charge on the failure and 
mortality rate. 
 
The statistical packages StatView (version 5.0.1, SAS Institute Inc.) and 
SAS (version 8.2, SAS Institute Inc.) were employed for data analysis. 
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RESULTS 
 
Environmental conditions 
In Greenland immobilisations were performed on calm (n = 54, x̅= 2.3 m/s, 
range 0 – 12 m/s, SD = 2.1) and relatively warm days (n = 54, x̅ = 4.9 °C, 
range –1.0 - 12.3 °C, SD = 2.8); at Franz Josef Land it was usually calm (0 – 
6 m/s) and temperatures ranged between –8 °C and +3 °C. 
 
Improvement of the immobilisation protocol 
Behavioural responses during induction followed generally the sequence 
described by Griffiths et al. (1993) and Lanthier (1999). These corresponded 
to (1) mild and brief alertness upon darting, (2) return to resting position, (3) 
resumed mild alertness with gradual impairment of the ability to raise the 
head, and finally (4) twitching and lumbar muscle spasms at which point the 
animal was considered safe to approach and administration of the antagonist. 
In addition to the protocol described by Griffiths et al. (1993) and Lanthier et 
al. (1999) and early seasons described in this study, in 1999-2001 after the 
administration of the antagonist the walruses were routinely intubated to 
prevent asphyxia due to etorphine-induced muscle contractions around the 
airways. This operation was usually initiated relatively late during apnoea. 
Due to contraction of the muscles around the jaw, glottis and pharynx it was 
sometimes difficult to insert the tube and forced, opening of the glottis by 
hand was required. Forced ventilation using an inflatable boat, double action, 
hand pump (4 L capacity) seemed useful for testing the correct placement of 
the tube and during the initial part of the recovery phase. Emergency hand 
pump ventilation was also attempted in three of the five mortalities. In 
general, routine intubation alone, by ensuring opening of the glottis, seemed 
very to be useful in helping the animals regain full spontaneous ventilation. 
 
Differences between males and females 
There was no significant difference in the relative total dose of etorphine 
administered to males and females (Mann-Whitney U-test, P = 0.06). 
Likewise no significant difference between males and females was observed 
for apnoea start (Mann-Whitney U-test, P = 0.11), apnoea duration (Mann-
Whitney U-test, P = 0.43), time of first injection of diprenorphine (Mann-
Whitney U-test, P = 0.79), amount of diprenorphine administered as a first 
dose (Mann-Whitney U-test, P = 0.42) or time of first breath after etorphine 
administration (Mann-Whitney U-test, P = 0.08). 
 
First time immobilisations (group A) 
The estimated total body mass of the animals in group A ranged from 633 to 
1883 kg (Table 3). A total of between 4 and 10 mg etorphine was administered 
per individual walrus at an estimated mean dose of 6.0 μg/kg (Table 3). 
Higher etorphine doses had shorter induction times (“log-induction time in 
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min” = 1.068 - 0.55 * “etorphine dose in µ/TBM in kg”, R2 = 0.275, p = 0.004, 
n = 28). 
 
Apnoea was induced in all animals at a mean of 5.0 min after injection of 
etorphine (Table 3). Apnoea lasted 13.7 min (Table 3). The antagonist 
diprenorphine was administered 8.4 min after darting (Table 3) at a mean first 
dose of 12.2 mg (n = 39, range 6.0 - 21.0 mg, SD = 3.5). The total dose of 
diprenorphine delivered to the animals that were successfully immobilised 
ranged from 7.7 to 41.7 μg/kg (Table 3). For the same individuals the 
recovery phase, beginning from the first breathing act after the apnoeic 
period, started between 11.5 and 34.0 min from the injection of etorphine (n = 
30, x̅ = 18.7 min, SD = 6.0). 
 
The duration of apnoea and the dose of etorphine were apparently not 
correlated (“log-duration of apnoea in min” = 1.211 - 0.136 * “log-g/kg 
etorphine”, R2 = 0.03, p = 0.40, n = 27). However, if the antagonist was 
injected relatively late, the apnoeic period became longer. There was 
significant positive correlation between the time of injection of the first dose 
of antagonist and the duration of apnoea (“log-duration of apnoea in min” = 
0.697 - 0.451 * “log-time of injection of antagonist in min”, R2 = 0.20, p = 
0.011, n = 33).  
 
 
Table 3. Summary of first-time immobilisations (group A) presented in this 
study. “Induction time” represents the time between etorphine administration 
and complete immobilisation. “Diprenorphine Dose” represents the total dose 
of diprenorphine administered. And “Diprenorphine time” represents the time 
for the first dose. 
 
 
Body 
mass 
(kg) 
Etorphine 
dose 
(μg/kg) 
Induction 
time 
(min) 
Diprenorphine  Duration of 
apnoea 
(min) 
Dose 
(μg/kg) 
Time 
(min) 
Mean 1310 6.0 5.0 17.2 8.4 13.7 
Range 
633 - 
1883 
2.4 - 12.6 1.9 - 12.4 
7.7 -   
41.7 
4.7 -      
18.0 
17.0 - 26.7 
SD 294 2.4 2.2 7.5 2.8 5.1 
n 34 33 38 31 38 36 
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Respiration rate of undisturbed resting walruses was 3.9 breaths/minute (n = 
23, SD = 0.82). The breathing rate following apnoea was 9 breaths/min (n = 
29, range 1 – 32 breaths/minute, SD = 6) up to 30 min from induction. During 
the following 175 min, the average breathing rate decreased (breath/min = 
17.34 - 2.48 * “log-min after induction”; R2 = 0.094). In particular, after 60 
min from induction it was 6 breaths/min (n = 16, range 2 – 20 breaths/minute, 
SD = 4). 
 
The pulse of one undisturbed animal before it received a dose of etorphine 
was observed from movements of the ventral skin at 55 beats/min (similarly 
two other hauled-out animals, not subsequently drugged, showed a pulse of 
48 and 52 beats/min respectively). A separate study (Bertelsen et al. 2006) 
measured the pulse of undisturbed, un-drugged, adult walruses from the same 
area to average 36 beats/min (SD = 3.7, n = 10). After drug delivery, during 
the apnoeic phase the pulse of this animal had risen to 60 beats/min. For all 
animals (n = 10) pulse rate during apnoea averaged 54 beats/min (range 40 – 
80 beats/min, SD = 13.6). Generally there was no significant difference 
(t-test, t = 1.830, p > 0.05, df = 32) between the pulse of the animals in the 
apnoeic and the post-apnoeic phase (n = 24, x̅ = 63 beats/min, range 38 – 
94 beats/min, SD = 13.8). The pulse of 8 animals was measured both during 
apnoea and during the recovery phase. Also in this case there was no 
significant difference between pulse during the two periods (t-test, t = 1.233, 
p = 0.257, df = 7). 
 
Rectal temperature during the apnoeic period measured 36.7 °C (n = 6, 
range 36.2 – 37.5 °C, SD = 0.51). During the same period peripheral 
temperature was 35.2 °C (n = 6, range 34.1 – 36.4 °C, SD = 0.88). In the 
recovery phase internal temperature was still 36.7 °C (n = 15, range 35.3 – 
38.4 °C, SD = 0.82), whereas peripheral temperature was 30.1 °C (n = 13, 
range 13.9 – 36.1 °C, SD = 6.11). For 4 animals internal temperature was 
recorded both during apnoea and the recovery period, but no significant 
difference was found between the two (paired t-test, t = 0.960, p = 0.408, df = 
3). Likewise, peripheral temperature measured at the hind flipper showed no 
significant difference between the same two periods (paired t-test, t = 1.143, 
p = 0.34, df = 3). 
 
Of the 41 animals immobilised in this group, full immobilisation was 
achieved in 32 cases, failure to restrain the animal occurred on five occasions 
and four animals died. Two of the casualties (see section Mortality) occurred 
during or immediately after handling. 
 
Blood pH-values were measured in five animals between 20 min and three 
hours from induction. Values ranged between 6.8 and 7.2 (Fig. 1). 
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Fig 1. pH-values in blood of five Atlantic walrus (Odobenus 
rosmarus rosmarus) (Greenland 2001) during apnoea and the 
post-apnoeic period following immobilisation with etorphine. 
 
 
Multiple immobilisations (group B) 
This group was administered the agonist dose under the same conditions as 
for group A. The estimated total body mass of the animals in group B ranged 
from 1050 to 1600 kg (Table 4). A total of between 4 and 9.8 mg etorphine 
was administered per individual walrus at an estimated mean dose of 
6.4 μg/kg (Table 4). 
 
Apnoea was induced in all animals 4.1 min (Table 4) after injection of 
etorphine and lasted 14.6 min (Table 4). A first dose of 11.3 mg (n = 35, range 
3.0 - 21.0 mg, SD = 3.3) of the antagonist diprenorphine was administered at 
a mean of 7.8 min after darting (Table 4). The total dose of diprenorphine 
delivered to the animals that were successfully immobilised ranged from 7.7 
to 32.2 μg/kg (Table 4). 
 
The analysis of the effect of repeated anaesthesia on the induction time did 
not show any significant correlation between the different immobilisations of 
the same individual. Neither induction time nor apnoea duration were 
significantly different when (p > 0.05) compared with subsequent 
immobilisations, irrespective of the relative dose of the agonist or antagonist 
or the time incurring between the administrations of the two substances. This 
suggests that repeated immobilisation of an animal did not have any 
noticeable effect on induction time (i.e. no habituation or sensitisation to 
etorphine). 
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Table 4. Summary of multiple-time immobilisations (group B) of 10 
walruses presented in this study. Dose and time data include all 
immobilisations where data were available. “Induction time” represents the 
time between etorphine administration and complete immobilisation. 
“Diprenorphine Dose” represents the total dose of diprenorphine 
administered, and “Diprenorphine Time” represents the time for the first dose. 
 
 
Body 
mass 
(kg) 
Etorphine 
dose 
(μg/kg) 
Induction 
time 
(min) 
Diprenorphine  Duration of 
apnoea 
(min) 
Dose 
(μg/kg) 
Time 
(min) 
Mean 1220 6.4 4.1 15.6 7.8 14.6 
Range 
1050
-       
1600 
3.4 - 9.3 0.9 - 9.0 
7.7 -   
32.2 
2.9 -      
13.1 
4.8 -           
35.2 
SD 177 1.9 1.7 7.0 2.2 5.3 
n 10 36 36 35 35 36 
 
 
One animal (1989-3, Table 2) was immobilised with etorphine twice in 1989 
and once in 1990 and then treated again once in 2000 and twice in 2001. This 
ca. 31 year old animal died during the last immobilisation after it apparently 
had regained consciousness and was breathing autonomously. 
 
In 2000 and 2001, a subsample of the animals that were captured and 
immobilised several times were included in a study of body water content, 
body water turnover and energy metabolism involving the use of stable 
isotopes (deuterium oxide dilution and doubly-labelled water; Acquarone et 
al. 2006; Acquarone and Born 2007). It was essential for the study that the 
animals were kept sedated on the beach for repeated sampling of blood 
through the catheter during the time required for the equilibration of the 
injected fluids with the body water pool. In 32 cases it was possible to handle 
the animals taking advantage of their drowsiness (up to 2 hrs.) while they 
were recuperating from the etorphine / diprenorphine immobilisation. In 6 
cases it was necessary to administer medetomidine (reversed with Antisedan) 
to prolong the period in which they were tractable (Griffiths et al. 2014). 
When the animals were sufficiently lethargic as a side-effect of the 
immobilisation with etorphine, blood could be sampled up to 6.5 hours after 
darting.  
 
Mortality 
The overall mortality rate was 7 % (5 dead of 69). The five animals died 
during somewhat different circumstances: In 1989, one walrus had resumed 
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controlled and regular breath but was found dead 230 min after having 
regained consciousness (first breath). In 2001, two animals had apparently 
started breathing after injection of the antagonist. However, breathing never 
became deep and regular and instead it became increasingly shallow until it 
stopped. Walrus 1989-3 (Table 2) had been immobilised several times 
between 1989 and 2001. Another animal became apnoeic after injection of 
etorphine and never breathed again. A fifth animal resumed regular breathing 
and went into the water after having been treated. It was found dead, 8 days 
after immobilisation, and stranded in the tidal zone about 9 km from the haul-
out. 
 
Mortality was tested against etorphine dose, diprenorphine dose and timing 
of injection of the antagonist by bootstrap analysis, but there was no 
significant result for any of the factors (p > 0.05). 
 
Another side effect experienced was inability to fully immobilise an animal. 
In six cases the walruses were not sufficiently immobilised to allow for 
treatment. In one case in 1989 the animal (1989-3, Table 2) never became 
fully immobilised whereas in the in five other failed immobilisations the 
subject woke up during the initial phases of the treatment. These latter 
animals escaped into the water where they were apparently able to swim and 
dive in a coordinated fashion. 
 
The rates of mortality and failure to fully immobilise the animals apparently 
differed between the researchers in charge of the drugging (Table 5). 
However, these differences were not statistically significant (rate of mortality: 
χ2 = 6.82; p = 0.08; df = 3); failure to fully immobilise an animal plus 
mortality: χ2 = 7.44; p = 0.06; df = 3). 
 
In this study immobilisation was attempted 69 times. It was possible to obtain 
full immobilisation 58 times (84 %), in six cases (9 %) immobilisation failed 
and the animals were never completely restrained, while five individuals 
(7 %) died from the treatment for no apparent reason. Similarly Hills (1992) 
attempted immobilisation 59 times, resulting in eight (14 %) incomplete 
immobilisations and five (9 %) casualties in Pacific walruses. Griffiths et al. 
(1993) experienced 2 partial immobilisations (5 %) and one casualty (3 %) 
during 38 immobilisations of walruses in Svalbard. During six 
immobilisations at Svalbard in the subsequent years, two more casualties 
were experienced (Griffiths unpublished). Overall mortality was 7 % at 
Svalbard as well. Mortality rates experienced in these studies do not differ 
significantly (χ2-test, p > 0.05). Hence it can be concluded that etorphine 
reversed with diprenorphine may result in an overall mortality of 8 % (13 died 
of 172 handled) in walruses. 
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Table 5. Rates of mortality and failure to fully immobilise walruses in this 
study in relation to individual researchers in charge of the drugging.  
 
Researcher 
Total 
Immobilis-
ations 
Succeeded 
No. failed 
(%) 
No. died 
(%) 
Year 
1 17 15 1 (5.8) 1 (5.8) 
1989, 1990, 
1994 
2 9 9 0 (0) 0 (0) 1991, 1992 
3 22 22 2 (9.1) 0 (0) 2000 
4 21 14 3 (14.3) 4 (7.3) 2001 
All 69 60 4 (8.7) 5 (7.3) 1989-2001 
 
 
DISCUSSION 
 
The mean induction time of 5.0 min reported in this study for etorphine doses 
between 2.4 and 12.6 μg/kg does not differ statistically (t = 1.429; p > 0.05; 
df = 71) from the average induction time of 5.7 minutes, reported by Griffiths 
et al. (1993), where 3.3 to 9.6 μg/kg etorphine was used on Svalbard on 
Atlantic walruses, which were of similar size to those in Greenland (t = 1.567, 
p > 0.05, df = 67). 
 
In male Pacific walruses given etorphine the mean induction time reported 
was 15.4 min (n = 25, range 5.5 - 35.8 min, SD = 8.1) after administration of 
7.3 μg/kg of the drug (n = 21, range 4.0 - 2.7 μg/kg, SD = 0.39; Hills 1992). 
Although there was a significant difference in body size between the animals 
in the present study and the ones reported in Hills (1992; t-test, t = 4.951, p < 
0.001, df = 53), the relative dose of etorphine administered was similar (t-test, 
t = 2.453, p < 0.05, df = 52). When analysing the data in Hills (1992), similar 
to this study, it was not possible to find any correlation between dose of 
etorphine and induction time (linear regression analysis of dose – 
log-induction time; p = 0.42, R2 = 0.13, n = 51). However, mean induction 
time in Pacific walrus was significantly longer than found here (t-test, t = 
7.532, p < 0.001, df = 61). The surprisingly long induction time experienced 
in Hills (1992) may be ascribed to the shorter needles (6 – 8 cm) used for 
darting larger animals (some of the agonist may have been deposited in the 
skin and blubber) or to differences in the definition of “induction time”. In 
both studies, induction time is defined as the “number of minutes from darting 
until the animal is safe to approach,” however the parameter “safe to 
approach” is subjective and depends on the experience of the operator.  
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Etorphine depresses respiration by raising the threshold of the reflex of 
inspiration and by affecting stretch receptors in the lungs (Kock et al. 1987). 
Generally apnoea is induced at markedly lower levels of anaesthesia in 
marine mammals than in terrestrial mammals (Hammond and Elsner 1977). 
The drug-induced muscle tonus and apnoea observed in this study have also 
been reported when etorphine was used for immobilisation of phocidae 
(Haigh and Stewart 1979, Parry et al. 1981). The duration of apnoea in the 
present study was significantly longer than in Pacific walruses (Hills 1992; 
x̅ = 11.8 min, range 5.5 - 24.0 min, SD = 4.8, n = 22; t-test, t = 1.407, P > 
0.05, df = 56) and Atlantic walruses on Svalbard (Griffiths et al. 1993; x̅ = 
11.9 min, range 5.6 – 20.8 min, SD = 3.8, n = 35; t-test, t = 1.778, P > 0.05, 
df = 69). The differences observed between this study and the others only 
reinforce the point stated above that “beginning of apnoea” is a very 
subjective parameter to be utilized with care in the analysis. 
 
Aerobic dive limit in Atlantic walruses has been estimated at between 9.8 and 
10.5 min for 1100 to 1500 kg animals, respectively (Nowicki et al. 1997, Wiig 
et al. 1996). Observations of diving walruses in the wild indicate that this 
limit is rarely exceeded (Nowicki et al. 1997, Wiig et al. 1996). However, 
syntheses on body mass and diving capacity in pinnipeds (Boyd and Croxall 
1996, Schreer and Kovacs 1997) indicate that maximum aerobic dive duration 
in a 1500 kg walrus may be close to 25 min which has been confirmed by 
observations in the wild (Gjertz et al. 2001). In the present study, in seven 
cases the animal did not breathe for over 20 min with a maximum registered 
apnoea of 35 min. The markedly increased respiration rate during the 
recovery phase observed in all immobilisations indicates that the animals may 
be compensating for oxygen deficiency built up during narcosis. Furthermore 
Griffiths et al. (1993) noted that walruses immobilised with etorphine 
remained lethargic during the recovery phase and suggested that the 
prolonged apnoea produced metabolic acidosis. This supposition is confirmed 
by the measures of blood pH reported here. The generally smooth recovery 
and apparently unaffected long-term post-handling behaviour observed both 
in previous (Born and Knutsen 1992b, Born and Knutsen 1997) and in the 
present study indicate a large tolerance towards apnoea, hence low blood pH, 
in walruses during immobilisation. They suggest that respiratory and 
circulatory mechanisms serving long dives are maintained during anaesthesia 
with etorphine. 
 
Etorphine induces alterations in the number and distribution of -opioid 
receptors in the rat cerebral cortex if administered alone, but no apparent 
change was visible if etorphine administration was accompanied by the 
antagonist naloxone (Melone et al. 2000). With this in mind changes in the 
number and distribution of opioid receptors may accompany variations in the 
tolerance of the animals to the drug.  
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The analysis of repeated immobilisations of 10 individuals, both within and 
across the years, did not indicate any change in the effect of the drugs on the 
subjects. The fact that the animals in this study were subject to several 
immobilisation during a relative short time frame indicates a substantial 
tolerance to etorphine and perhaps more noteworthy to one of its side-effect: 
prolonged apnoea. However, accurate monitoring of physiological 
parameters, with particular attention to internal temperature, pulse, blood pH 
and glycaemia, during immobilisation is here advocated to acquire a deeper 
understanding of immobilisation by this and other techniques. 
 
A pulse of about 64 beats/minute during apnoea and early recovery was 
observed in this study. For comparison, during a study at Svalbard, Griffiths 
et al. (1993) noted a resting pulse which ranged between 52 and 66, whereas 
during deep narcosis the pulse was between 22 and 48 beats per min. Griffiths 
et al. (1993) stated, without presenting the details, that heart rates remained 
steady, but varied somewhat with the dose of drug received and that animals 
receiving a high etorphine dose showed lowest pulse rates. In a study of non-
drugged walruses Bertelsen et al. (2006) found a resting heart rate of 36 (SD 
= 3.7; range: 29–43). Although higher than the resting heart rate, the pulse 
during etorphine anaesthesia does not seem to present any threat to the 
animals. 
 
Etorphine is known to interfere with thermoregulation, causing hyperthermia 
or hypothermia dependent of ambient conditions and activity levels (Alford 
et al. 1974). However, the internal temperatures measured here were within 
the normal range reported for pinnipeds (Sweeney 1974, Whittow 1987) 
indicating that thermoregulation was not severely affected during 
immobilisation. Also in other studies where walruses were immobilised with 
etorphine or carfentanil there have been no apparent thermoregulatory 
problems. Reported body temperatures in other studies ranged between 34.2 
and 37.9C (Griffiths et al. 1993, Hills 1992, Lanthier et al. 1999). The fall 
in peripheral body temperature reported in this study from 35°C to 28°C 
indicates that peripheral circulation control is not impaired by etorphine.  
 
The blood pH-value measured during apnoea for one animal (2001-6, Fig.1) 
was 6.8 which increased to 7.2 two hours after induction (corresponding to 
2.7 hrs. of active ventilation). A second animal (2001-2, Fig.1) presented a 
blood pH of 6.9 at the end of apnoea, which increased to 7.1 half an hour later. 
The low values of in blood pH at the end of the apnoeic period are probably 
to be ascribed to the hypercapnia and reflect immobilisation-induced stress. 
However, the blood pH became normal relatively shortly after resumption of 
respiratory function.  
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The dosage of etorphine varies widely for all walrus studies mainly due to 
differences in animal TBM. The latter is a difficult parameter to assess at a 
distance in a field situation. However, after having experienced a case of 
under-dosage (4 mg corresponding to 2.4 μg/kg) in 1989, a total injection of 
between 6 and 10 mg etorphine irrespective of the size of the animals was 
routinely used. In most cases this resulted in successful immobilisation of the 
animal. This confirms that it is advisable to administer the maximum dose of 
etorphine, rather than the minimum effective dosage, and then reverse 
promptly with an appropriate dose of antagonist (Alford et al. 1974, Booth 
1988), because under-dosage may cause severe physiological and behavioural 
reactions (Alford et al. 1974) such as hyperexcitability, hyperventilation and 
subsequent alkalosis leading to death at a later time in the recovery phase. 
 
Re-narcotisation has been suggested to explain the death of walruses 
immobilised with carfentanil and subsequently antagonized with naloxone 
(Hills 1992). In other mammals, re-narcotisation has been observed from 2 to 
72 hrs. post-immobilisation (Allen 1990, Haigh et al. 1983, Jacobson et al. 
1988, Jessup et al. 1985, Seal et al. 1985). The present study suggests that re-
narcotisation could serve as an explanation for cause of death in the three 
cases in which animals had regained breath and apparently had come out of 
the immobilisation. In these cases sufficient amounts of diprenorphine were 
given to bring the animals to full ventilation. However, as doses were 
routinely injected in more than one site to secure absorption, it might be that 
some of it was deposited in blubber. The deposition of antagonists with longer 
half-life such as naltrexone, alone or in combination with diprenorphine, was 
not tested and it might be considered for future occasions. 
 
The researchers who were in charge of the immobilisations prior to 2001 all 
had several seasons of experience with using this drug combination for 
immobilising walrus. This is in contrast with the situation in 2001 when a 
relative high mortality and failure-to-immobilise rate was experienced. 
Familiarity with the effects of etorphine and diprenorphine in walrus and with 
walrus anatomy is in our opinion crucial. The secure administration of the 
antagonist into muscle or other metabolically active tissues is important to 
prevent suffocation. On the other hand injecting the antagonist directly into a 
vein or a blood vessel sinus may result in the animals waking up prematurely.  
 
In this study short-term monitoring by visual observation showed no sign of 
adverse effects of the immobilisation treatment. However, the rates of 
mortality and premature awakening were relatively high. Furthermore the 
induction of prolonged apnoea with associated acidosis is an undesirable side 
effect of this immobilisation technique. It is here recommended that etorphine 
reversed with diprenorphine for immobilisation of walrus should be used only 
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for short term handling, and that experiments in search for a more suitable 
agent for long-term immobilisation should be effectuated. 
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